The critical role of kinase activity of interleukin-1 receptor-associated kinase 4 in animal models of joint inflammation
- PMID: 19479877
- DOI: 10.1002/art.24552
The critical role of kinase activity of interleukin-1 receptor-associated kinase 4 in animal models of joint inflammation
Abstract
Objective: We have previously reported that the kinase activity of interleukin-1 receptor-associated kinase 4 (IRAK-4) is important for Toll-like receptor and interleukin-1 receptor signaling in vitro. Using mice devoid of IRAK-4 kinase activity (IRAK-4 KD mice), we undertook this study to determine the importance of IRAK-4 kinase function in complex disease models of joint inflammation.
Methods: IRAK-4 KD mice were subjected to serum transfer-induced (K/BxN) arthritis, and migration of transferred spleen lymphocytes into joints and cartilage and bone degradation were assessed. T cell response in vivo was tested in antigen-induced arthritis (AIA) by measuring the T cell-dependent antigen-specific IgG production and frequency of antigen-specific T cells in the spleen and lymph nodes. T cell allogeneic response was tested in vitro by mixed lymphocyte reaction (MLR).
Results: Lipopolysaccharide-induced local neutrophil influx into subcutaneous air pouches was impaired in IRAK-4 KD mice. These mice were also protected from inflammation in the K/BxN and AIA models, as shown by reduced swelling of joints. Histologic analysis of joints of K/BxN serum-injected mice revealed that bone erosion, osteoclast formation, and cartilage matrix proteoglycan loss were reduced in IRAK-4 KD mice. Assessment of T cell response by MLR, by frequency of antigen-specific clones, and by production of antigen-specific IgG did not reveal substantial differences between IRAK-4 KD and wild-type mice.
Conclusion: These results demonstrate that IRAK-4 is a key component for the development of proarthritis inflammation, but that it is not crucial for T cell activation. Therefore, the kinase function of IRAK-4 appears to be an attractive therapeutic target in chronic inflammation.
Comment in
-
Interleukin-1 receptor-associated kinase 4 links innate immunity to the pathogenesis of rheumatoid arthritis.Arthritis Rheum. 2009 Jun;60(6):1571-4. doi: 10.1002/art.24546. Arthritis Rheum. 2009. PMID: 19479874 No abstract available.
Similar articles
-
Survival and cardiac remodeling after myocardial infarction are critically dependent on the host innate immune interleukin-1 receptor-associated kinase-4 signaling: a regulator of bone marrow-derived dendritic cells.Circulation. 2009 Oct 6;120(14):1401-14. doi: 10.1161/CIRCULATIONAHA.109.865956. Epub 2009 Sep 21. Circulation. 2009. PMID: 19770394
-
Interleukin-1 receptor-associated kinase 4 links innate immunity to the pathogenesis of rheumatoid arthritis.Arthritis Rheum. 2009 Jun;60(6):1571-4. doi: 10.1002/art.24546. Arthritis Rheum. 2009. PMID: 19479874 No abstract available.
-
The interleukin-1 receptor-associated kinases: critical regulators of innate immune signalling.Biochem Pharmacol. 2010 Dec 15;80(12):1981-91. doi: 10.1016/j.bcp.2010.06.020. Epub 2010 Jun 23. Biochem Pharmacol. 2010. PMID: 20599782 Review.
-
IRAK-4 kinase activity is required for IRAK-4-dependent innate and adaptive immune responses.Eur J Immunol. 2008 Mar;38(3):870-6. doi: 10.1002/eji.200737429. Eur J Immunol. 2008. PMID: 18286567
-
IRAK-4--a shared NF-kappaB activator in innate and acquired immunity.Trends Immunol. 2006 Dec;27(12):566-72. doi: 10.1016/j.it.2006.10.003. Trends Immunol. 2006. PMID: 17046325 Review.
Cited by
-
Deep Learning-Driven Library Design for the De Novo Discovery of Bioactive Thiopeptides.ACS Cent Sci. 2023 Nov 7;9(11):2150-2160. doi: 10.1021/acscentsci.3c00957. eCollection 2023 Nov 22. ACS Cent Sci. 2023. PMID: 38033794 Free PMC article.
-
Irak-4 rs4251481 gene variant: as a risk factor on inflammatory bowel disease.Turk J Med Sci. 2019 Apr 18;49(2):478-482. doi: 10.3906/sag-1807-279. Turk J Med Sci. 2019. PMID: 30997787 Free PMC article.
-
Emerging interleukin-1 receptor-associated kinase 4 (IRAK4) inhibitors or degraders as therapeutic agents for autoimmune diseases and cancer.Acta Pharm Sin B. 2024 Dec;14(12):5091-5105. doi: 10.1016/j.apsb.2024.09.008. Epub 2024 Sep 14. Acta Pharm Sin B. 2024. PMID: 39807338 Free PMC article. Review.
-
TAK1 signaling is a potential therapeutic target for pathological angiogenesis.Angiogenesis. 2021 Aug;24(3):453-470. doi: 10.1007/s10456-021-09787-5. Epub 2021 May 10. Angiogenesis. 2021. PMID: 33973075 Review.
-
Interleukin 1/Toll-like receptor-induced autophosphorylation activates interleukin 1 receptor-associated kinase 4 and controls cytokine induction in a cell type-specific manner.J Biol Chem. 2014 Apr 11;289(15):10865-10875. doi: 10.1074/jbc.M113.544809. Epub 2014 Feb 24. J Biol Chem. 2014. PMID: 24567333 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases